SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-005296
Filing Date
2020-03-16
Accepted
2020-03-16 15:24:10
Documents
8
Period of Report
2020-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20200315b_8k.htm 8-K 65990
2 EXHIBIT 2.1 ex_177370.htm EX-2.1 1011237
3 EXHIBIT 10.1 ex_177371.htm EX-10.1 147190
4 EXHIBIT 10.2 ex_177372.htm EX-10.2 81736
5 EXHIBIT 10.3 ex_177381.htm EX-10.3 71040
6 EXHIBIT 10.4 ex_177373.htm EX-10.4 176901
7 EXHIBIT 99.1 ex_177382.htm EX-99.1 25985
8 logo.jpg GRAPHIC 18839
  Complete submission text file 0001437749-20-005296.txt   1607259
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 20716844
SIC: 2834 Pharmaceutical Preparations